These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 578447)

  • 1. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial pyrogens of different origin and pharmacokinetics of rifampicin.
    Lavický J; Urbanová Z; Celeda L; Rasková H; Kvĕtina J; Vanĕcek J; Krecek J
    Arzneimittelforschung; 1987 Jun; 37(6):713-6. PubMed ID: 3663270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and saliva concentrations of rifampicin in man after oral administration.
    Orisakwe OE; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):45-9. PubMed ID: 9239804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of rifampicin in gastrectomized patients. Effect of meals.
    Hagelund CH; Wåhlén P; Eidsaunet W
    Scand J Respir Dis; 1977 Oct; 58(5):241-6. PubMed ID: 601547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary note on the use of parenteral rifampicin (slow venous infusion). Blood levels and tolerance].
    Giura R; Scardaccione M; Roccamo B; Giura C
    G Ital Chemioter; 1978; 25(1):45-8. PubMed ID: 751848
    [No Abstract]   [Full Text] [Related]  

  • 7. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations.
    Burrows GE; MacAllister CG; Beckstrom DA; Nick JT
    Am J Vet Res; 1985 Feb; 46(2):442-6. PubMed ID: 3994110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on the serum and lung tissue level of rifampicin in man.
    Kiss IJ; Faragó E; Juház I; Bacsa S; Fábián E
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):42-7. PubMed ID: 1248917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosmidomycin: a new phosphonic acid antibiotic. Part I: Phase I tolerance studies.
    Kuemmerle HP; Murakawa T; Soneoka K; Konishi T
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):515-20. PubMed ID: 4066075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT; Vakhmistrova TI; Perova TL
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probenecid on serum rifampicin levels.
    Pankaj R; Lal S; Rao RS
    Indian J Lepr; 1985; 57(2):329-33. PubMed ID: 4078358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of rifampicin caplets (600 mg and 450 mg) in healthy Indonesian subjects.
    Ganiswarna SG; Wilmana PF; Setiabudy R; Ringoringo VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):60-4. PubMed ID: 3957493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of rifampicin following intranasal and oral administration.
    Mamidi NV; Prabhakar MC; Krishna DR
    Indian J Lepr; 1996; 68(2):149-53. PubMed ID: 8835583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental pharmacodynamic study of rifampicin administered by various methods].
    Shapovalov VP; Mil'chenko KP; Kovalenko NN
    Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of fosmidomycin, a new phosphonic acid antibiotic.
    Kuemmerle HP; Murakawa T; De Santis F
    Chemioterapia; 1987 Apr; 6(2):113-9. PubMed ID: 3594633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of rifampicin administered intravenously to pulmonary tuberculosis patients].
    Ziia AV; Sokolov GB; Firsov AA
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):223-7. PubMed ID: 3579252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
    Karkishchenko NN; Vorob'ev VS; Khoron'ko VV; Anisimova NB; Chubarian VT
    Vrach Delo; 1988 Dec; (12):72-3. PubMed ID: 3245176
    [No Abstract]   [Full Text] [Related]  

  • 20. The renal elimination of rifampicin as a function of the oral dose. A convenient way to assess relative bioavailability.
    Brechbühler S; Fluehler H; Riess W; Theobald W
    Arzneimittelforschung; 1978; 28(3):480-3. PubMed ID: 580761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.